Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

19.32 -0.93 (-4.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,619
Open 20.25
Bid (Size) 19.10 (84)
Ask (Size) 19.42 (35)
Prev. Close 20.25
Today's Range 19.06 - 20.67
52wk Range 2.700 - 38.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Launches $600 Private Placement of Class A Multiple Voting Shares
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Backs Unbuzzd’s $5 Million Raise via Regulation D Offering
Via Investor Brand Network
Topics Initial Public Offering

Performance

YTD
+373.5%
+373.5%
1 Month
+27.1%
+27.1%
3 Month
+150.6%
+150.6%
6 Month
+378.2%
+378.2%
1 Year
+352.5%
+352.5%

More News

Read More
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
From Quantum BioPharma
Via GlobeNewswire
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
These stocks are gapping in today's session
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gapping stocks in Friday's session
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Brain and Alcohol Health Pipeline, Receives Phase 2 Trial Approval for FSD202
Via Investor Brand Network
Topics Initial Public Offering
Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress
Via Newsfile
Topics Initial Public Offering
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Begins First MS Patient Scan in MGH PET Imaging Study
Via Investor Brand Network
Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital
From Quantum BioPharma
Via GlobeNewswire
TinyGemsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Plans Special Dividend Linked to Litigation Proceeds
Via Investor Brand Network
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
From Quantum BioPharma
Via GlobeNewswire
Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000
From Quantum BioPharma
Via GlobeNewswire
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Clarifies Name, Ownership, and RTO Rumors Involving unbuzzd
Via Investor Brand Network
Topics Initial Public Offering
Quantum BioPharma Clarifies It Has Not Changed Its Name
From Quantum BioPharma
Via GlobeNewswire
What's Going On With Quantum Biopharma Stock Today?
Via Benzinga
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Finalizes $2.35 Million Settlement with Former CEO Raza Bokhari
Via Investor Brand Network
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
From Quantum BioPharma
Via GlobeNewswire
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Announces Auditor Appointment and Name Change for Unbuzzd Wellness
Via Investor Brand Network
Topics Initial Public Offering
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.
From Quantum BioPharma
Via GlobeNewswire

Frequently Asked Questions

Is Quantum Biopharma Ltd. - Class B Subordinate Voting Shares publicly traded?
Yes, Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is publicly traded.
What exchange does Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trade on?
Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
The ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is QNTM on the Nasdaq Stock Market
What is the current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
The current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is 19.32
When was Quantum Biopharma Ltd. - Class B Subordinate Voting Shares last traded?
The last trade of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares was at 07/01/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.